PIK3CA and cervical cancer: Furthermore, pretreatment with BYL-719 and removing the drug, followed by treatment with donor T cells, had the maximum effect.<h4>Conclusions</h4>Our study revealed molecular inhibitors targeting mutant <i>PIK3CA</i> cervical cancer.